85
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Chemokine receptor CXCR3 facilitates CD8 + T cell differentiation into short-lived effector cells leading to memory degeneration

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          CXCR3 regulates CD8 + T cell recruitment to sites of inflammation, thus dictating CD8 + T cell contraction and subsequent effector/memory cell fate.

          Abstract

          Strength of inflammatory stimuli during the early expansion phase plays a crucial role in the effector versus memory cell fate decision of CD8 + T cells. But it is not known how early lymphocyte distribution after infection has an impact on this process. We demonstrate that the chemokine receptor CXCR3 is involved in promoting CD8 + T cell commitment to an effector fate rather than a memory fate by regulating T cell recruitment to an antigen/inflammation site. After systemic viral or bacterial infection, the contraction of CXCR3 −/− antigen-specific CD8 + T cells is significantly attenuated, resulting in massive accumulation of fully functional memory CD8 + T cells. Early after infection, CXCR3 −/− antigen-specific CD8 + T cells fail to cluster at the marginal zone in the spleen where inflammatory cytokines such as IL-12 and IFN-α are abundant, thus receiving relatively weak inflammatory stimuli. Consequently, CXCR3 −/− CD8 + T cells exhibit transient expression of CD25 and preferentially differentiate into memory precursor effector cells as compared with wild-type CD8 + T cells. This series of events has important implications for development of vaccination strategies to generate increased numbers of antigen-specific memory CD8 + T cells via inhibition of CXCR3-mediated T cell migration to inflamed microenvironments.

          Related collections

          Most cited references56

          • Record: found
          • Abstract: found
          • Article: not found

          T-cell priming by dendritic cells in lymph nodes occurs in three distinct phases.

          Primary T-cell responses in lymph nodes (LNs) require contact-dependent information exchange between T cells and dendritic cells (DCs). Because lymphocytes continually enter and leave normal LNs, the resident lymphocyte pool is composed of non-synchronized cells with different dwell times that display heterogeneous behaviour in mouse LNs in vitro. Here we employ two-photon microscopy in vivo to study antigen-presenting DCs and naive T cells whose dwell time in LNs was synchronized. During the first 8 h after entering from the blood, T cells underwent multiple short encounters with DCs, progressively decreased their motility, and upregulated activation markers. During the subsequent 12 h T cells formed long-lasting stable conjugates with DCs and began to secrete interleukin-2 and interferon-gamma. On the second day, coinciding with the onset of proliferation, T cells resumed their rapid migration and short DC contacts. Thus, T-cell priming by DCs occurs in three successive stages: transient serial encounters during the first activation phase are followed by a second phase of stable contacts culminating in cytokine production, which makes a transition into a third phase of high motility and rapid proliferation.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Lineage relationship and protective immunity of memory CD8 T cell subsets.

            Memory CD8 T cells can be divided into two subsets, central (T(CM)) and effector (T(EM)), but their lineage relationships and their ability to persist and confer protective immunity are not well understood. Our results show that T(CM) have a greater capacity than T(EM) to persist in vivo and are more efficient in mediating protective immunity because of their increased proliferative potential. We also demonstrate that, following antigen clearance, T(EM) convert to T(CM) and that the duration of this differentiation is programmed within the first week after immunization. We propose that T(CM) and T(EM) do not necessarily represent distinct subsets, but are part of a continuum in a linear naive --> effector --> T(EM) --> T(CM) differentiation pathway.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Effector and memory CTL differentiation.

              Technological advances in recent years have allowed for an ever-expanding ability to analyze and quantify in vivo immune responses. MHC tetramers, intracellular cytokine staining, an increasing repertoire of transgenic and "knockout" mice, and the detailed characterization of a variety of infectious models have all facilitated more precise and definitive analyses of the generation and function of cytotoxic T lymphocytes (CTL). Understanding the mechanisms behind the differentiation of effector and memory CTL is of increasing importance to develop vaccination strategies against a variety of established and emerging infectious diseases. This review focuses on recent advances in our understanding of how effector and memory CTL differentiate and survive in vivo in response to viral or bacterial infection.
                Bookmark

                Author and article information

                Journal
                J Exp Med
                J. Exp. Med
                jem
                The Journal of Experimental Medicine
                The Rockefeller University Press
                0022-1007
                1540-9538
                1 August 2011
                : 208
                : 8
                : 1605-1620
                Affiliations
                [1 ]Department of Molecular Preventive Medicine , [2 ]MD Scientist Training Program , [3 ]Department of Immunotherapeutics (Medinet), Graduate School of Medicine , and [4 ]Center for NanoBio Integration (CNBI), The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-0033, Japan
                [5 ]Department of Immunology, Kinki University Faculty of Medicine, 377-2 Ohno-Higashi, Osaka-Sayama-shi, Osaka 589-8511, Japan
                [6 ]Japan Science and Technology Agency, Core Research for Evolutional Science and Technology, Chiyoda-ku, Tokyo 102-0075, Japan
                Author notes
                CORRESPONDENCE Kouji Matsushima: koujim@ 123456m.u-tokyo.ac.jp
                Article
                20102101
                10.1084/jem.20102101
                3149224
                21788406
                235ae0de-2ab4-4861-96dd-b478931977ed
                © 2011 Kurachi et al.

                This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.rupress.org/terms). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).

                History
                : 4 October 2010
                : 24 June 2011
                Categories
                Article

                Medicine
                Medicine

                Comments

                Comment on this article